Status:
COMPLETED
The Effect of Magnesium on Early Post-transplantation Glucose Metabolism
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
Astellas Pharma Inc
Conditions:
Glucose Metabolism After Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypomagnesemia is common early after transplantation, especially in association with calcineurin inhibitors and predicts diabetes after transplantation. Magnesium improves glycemic control and insulin...
Eligibility Criteria
Inclusion
- Renal transplantation recipients
- \> 18 years of age
- Less than 2 weeks post-transplantation
- Hypomagnesemia \< 1,7 milligram/deciliter on 2 consecutive blood samples (laboratory reference interval 1,7 - 2,55 milligram/deciliter).
Exclusion
- Pre-existing diabetes mellitus defined as the intake of anti-diabetic drugs at the time of inclusion
- Serum creatinine \> 3 milligram/deciliter
- Active infection (C reactive protein \> 3 milligram/deciliter)
- Severe hypomagnesemia (\< 1,2 milligram/deciliter)
- Hypokalemia (\< 3,5 milli-equivalent/liter)
- Severe hypocalcemia (\< 6,5 milligram/deciliter)
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT01889576
Start Date
January 1 2010
End Date
September 1 2012
Last Update
June 28 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital
Ghent, Belgium, 9000